Marsh & McLennan Companies, Inc. (MRSH) AI Stock Analysis

Marsh & McLennan Companies, Inc. is a global professional services firm delivering solutions in risk management, strategy, and human capital consulting. The company operates through two main segments: Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk assessment, mitigation strategies, catastrophe modeling, financial advisory, and insurance and reinsurance broking services to businesses, public entities, and private clients. The Consulting segment delivers health, wealth, and career consulting to optimize organizational performance, alongside management consulting covering economic analysis, brand strategy, and advisory services. Founded in 1871 and headquartered in New York City, it employs 95,000 people.

Between FY2021 and FY2025, Marsh & McLennan increased annual revenue from $19.82B to $26.98B, reflecting a 5-year compound annual growth rate of 9.4%. Operating margin reached 23.1% in FY2025, while gross margin stood at 42.3%. Over the same period, net income rose from $3.14B in FY2021 to $4.16B in FY2025, yielding an EPS of $9.75. In the trailing twelve months ending September 30, 2026, revenue stood at $28.46B with a profit margin of 14.2% and an operating margin of 18.4%. In the latest quarter, quarterly revenue growth was 8.1% year-over-year, and quarterly earnings grew 11.9%.

As of September 30, 2026, Marsh & McLennan held $1.84B in cash and short-term investments against total debt of $22.33B, resulting in net debt of $20.49B. Shareholders' equity was $14.68B, yielding a debt-to-equity ratio of 1.52, while the current ratio stood at 1.09. In FY2025, operating cash flow reached $5.29B and free cash flow was $5.00B. Capital expenditures were $291.0M. The company deployed cash toward shareholder returns in FY2025, funding $2.01B in share buybacks and $1.70B in dividends paid, reducing share count by 6.3% over five years.

MRSH carries a market cap of $89.88B and an enterprise value of $118.05B. The stock trades at a trailing P/E of 22.5x and a forward P/E of 15.0x, both higher than the median of its S&P 500 Financial Services peers at 14.2x and 12.2x, respectively. Its price-to-sales ratio is 3.2x versus the peer median of 3.1x, while its EV-to-EBITDA stands at 16.3x compared to 15.1x for peers. Over the past year, the stock returned 3.2%, trailing the S&P 500 return of 16.8%. Over five years, the stock gained 26.0% compared to 83.0% for the index.

Marsh & McLennan pays a quarterly dividend with an annual forward payout of $3.96 per share, representing a dividend yield of 2.10%. The payout ratio is 30.9%. The company has paid consecutive dividends for 44 years and achieved a 5-year annualized dividend growth rate of 13.3%. Its last ex-dividend date was October 1, 2026.

Wall Street coverage consists of 5 Strong Buy, 2 Buy, 15 Hold, and 1 Sell ratings. The mean price target is $205.24, which is 9.0% above the last close of $188.35. For the current fiscal year ending December 31, 2026, analysts estimate EPS of $10.48 on revenue of $28.69B. For the next fiscal year, 23 analysts project EPS of $11.46 on revenue of $30.10B, representing 9.4% EPS growth. The company beat EPS estimates in each of the last 4 quarters.

This page is an AI-written research summary of Marsh & McLennan Companies, Inc. (MRSH). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MRSH income statement, MRSH balance sheet, MRSH key metrics, MRSH analyst forecast, MRSH chart. See the MRSH stock overview for the latest quote and news.